Verastem | VSTM - Gross Profit On Sales

Stock Price
6.09
Daily Change
-0.44 -6.67%
Monthly
12.89%
Yearly
-13.57%
Q2 Forecast
6.44

Verastem reported $14.64M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
AstraZeneca USD 12.39B 5M Dec/2025
Curis USD 1.14M 8.86M Dec/2025
Cytokinetics USD 17.76M 15.82M Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
Incyte USD 1.39B 118.68M Dec/2025
Laboratory Of America USD 993.2M 31.9M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
TG Therapeutics USD 154.43M 20.81M Dec/2025
Verastem USD 14.64M 14.1M Dec/2025